MKI67 and neoplasm: These results are consistent since the proliferation of apoptotic tumor cells, such as Ki-67, was low, confirming the ability of such nanostructures to serve as contrast agents, accumulating iron in tumor tissues and promoting a targeted delivery of the biological therapeutic agent.